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ABSTRACT: Escherichia coli has been widely used as a platform
microorganism for both membrane protein production and cell factory
engineering. The current methods to produce membrane proteins in this
organism require the induction of target gene expression and often result
in unstable, low yields. Here, we present a method combining a
constitutive promoter with a library of bicistronic design (BCD) elements,
which enables inducer-free, tuned translation initiation for optimal protein
production. Our system mediates stable, constitutive production of
bacterial membrane proteins at yields that outperform those obtained
with E. coli Lemo21(DE3), the current gold standard for bacterial
membrane protein production. We envisage that the continuous, ﬁne-tunable, and high-level production of membrane proteins
by our method will greatly facilitate their study and their utilization in engineering cell factories.
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The high-level heterologous production of membraneproteins in E. coli and other hosts has proven challenging,
especially due to oversaturation of the membrane protein
biogenesis machinery.1 Common systems for recombinant
protein production, such as those based on the strong T7
promoter, often lead to the jamming of chaperones and
membrane translocation systems, consequently making it
impossible to produce correctly folded membrane proteins at
high levels.1,2
Several E. coli strains and expression systems have been
developed to improve the production of especially bacterial
membrane proteins. Commonly used systems include the E.
coli Walker strains (C41(DE3),C43(DE3)),3 E. coli BL21-AI,4
and the more recently developed E. coli Lemo21(DE3).5−7
These systems rely on downregulating the levels of T7 RNA
polymerase (T7RNAP), consequently reducing expression
rates to better accommodate translocation and folding of
membrane proteins.8 Particularly, E. coli Lemo21(DE3) has
been constructed to ﬁne-tune transcription through an indirect
control of T7RNAP activity through L-rhamnose-inducible
production of its inhibitor, T7-lysozyme (LysY).5−7 The
system has proven successful and has been recently stream-
lined into a one-plasmid system named pReX,9 but it requires
the properly timed addition of two diﬀerent inducer
compounds: L-rhamnose and the expensive IPTG (isopropyl
β-D-1-thiogalactopyranoside). Additionally, to date, neither
Lemo21(DE3) nor any other currently available system has
successfully demonstrated long-term (>24 h) continuous
production of membrane proteins in E. coli. Realizing
inducer-free, stable production remains a major challenge,
which is relevant for many synthetic biology applications. This
includes, for example, the heterologous production of trans-
porter membrane proteins in microbial cell factories to be used
in (continuous) production processes, or signal-transduction
membrane proteins in strains that need to function as a
biosensor over a long time.
Another limitation in heterologous protein production
relates to ribosome binding site (RBS) accessibility.10−12
Several proteins, including membrane proteins, have been
categorized as “diﬃcult-to-produce” due to strong mRNA
secondary structures in the 5′ untranslated region (5′-UTR)
and in the start of the coding sequence (CDS), which impede
the proper translation initiation at the RBS.13,14 Some eﬀorts
aimed at resolving such structures rely on fusing well-expressed
short peptide tags to the N-terminus of membrane
proteins.13,15,16 However, fusion peptides can aﬀect protein
stability, structure, and function.13 Furthermore, translation
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initiation has been successfully improved by randomly
mutating nucleotides around the start codon,13,14,17 which
enhanced the production of several “diﬃcult-to-produce”
membrane proteins, but this method requires a high-
throughput screening or selection approach.
To overcome the limitations of state-of-the-art membrane
protein production, we explored an alternative method for
protein expression: the so-called bicistronic design elements
(BCDs).18 The system is based on a constitutive promoter and
tuning by using two RBSs that are translationally coupled. The
ﬁrst RBS mediates strong translation initiation of a short leader
peptide, while the second RBS, which is located within the
leader peptide’s CDS and drives the translation of the protein
of interest, has a tunable strength (Figure 1). It is hypothesized
that the intrinsic helicase activity of the ribosomes translating
the leader peptide can unwind potential secondary structures
of the mRNA, thereby eliminating translation initiation
problems near the second RBS and the start of the target
CDS.19
In this work, we employ a library of translational coupling
elements to tune and optimize the constitutive production of
several bacterial membrane proteins. A medium-strength,
constitutive promoter (P14) and 22 variable-strength transla-
tional coupling elements (BCDs) were selected from the work
of Mutalik et al.;18 the BCD elements can be inserted
seamlessly in the expression vector using a simple golden gate-
based cloning method20 (Figure 1).
We tested our system for the expression of four diﬀerent
membrane proteins: YidC, AraH, and two rhodopsins. YidC is
a membrane-translocation chaperone in E. coli, which has been
frequently used as a model for studying membrane protein
production.6,21,22 AraH is the integral membrane component
of the E. coli arabinose ABC transporter, which is considered a
“diﬃcult-to-produce” protein because of its translation
initiation limitations in a typical pET vector;13,14 GR is a
proton-pumping rhodopsin photosystem from the cyanobacte-
rium Gloeobacter violaceus, and TR is a thermophilic rhodopsin
from Thermus thermophilus.
For the two ﬁrst proteins, YidC and AraH, GFP was fused to
their C-terminus, rendering YidC-GFP and AraH-GFP. All the
22 BCD variants were cloned separately into expression
vectors carrying YidC-GFP and AraH-GFP. We then estimated
levels of membrane inserted YidC and AraH by measuring
ﬂuorescence levels. C-terminal GFP only folds properly and
results in ﬂuorescence when membrane proteins fused to the
GFP are integrated into the membrane and do not end up in
inclusion bodies, hence providing a quantitative approximation
for membrane-embedded expression.23,24 The expression of
YidC-GFP and AraH-GFP by diﬀerent BCD elements was
ranked in order of the translation initiation strengths
previously observed for each BCD element in the work by
Mutalik et al.,18 in order to allow for a systematic analysis of
their ﬂuorescence (Figure 2a,e).
For both fusion proteins, the tested BCD variants resulted in
a range of GFP ﬂuorescence-signals, suggesting diﬀerent levels
of functional membrane protein production. In the case of
YidC-GFP, a rough pattern was observed considering the
correlation between the ﬂuorescence and the expected
translation initiation strength of the diﬀerent BCD constructs.
BCD elements up to BCD19 generally resulted in increased
levels of production, whereas elements stronger than BCD19
mostly resulted in lower production levels (Figure 2a). Some
of the strongest translation initiation variants resulted in
negligible and/or highly irreproducible production levels. For
example, in some replicate cultures the strong BCD2 gave high
expression but in several other cultures expression was
completely absent (ranging from no expression to 70 000
RFU/mL). When the BCD-based expression was compared to
the optimized Lemo21(DE3)-based expression of YidC-GFP,
the latter gave rise to an emerging nonproducing subpopula-
tion of cells after 22 h, as indicated by ﬂow cytometry analysis,
whereas the production by the highest-producing BCD19-
YidC-GFP remained homogeneous (Figure 2c). In agreement
with this observation, Western blot analysis revealed that the
formation of YidC-GFP in inclusion bodies was reduced for
the BCD19 versus optimized Lemo21(DE3)-expression
(Figure 2b). Moreover, the medium-strength BCD19 yielded
approximately twice as much production per cell than E. coli
Lemo21(DE3), which was previously proven to be a superior
production system for YidC-GFP over other commonly used
systems such as E. coli C41(DE3) and C43(DE3).6
In the case of AraH-GFP, a similar trend was observed, that
is, increasing levels of ﬂuorescence were measured up to
BCD19. However, unlike for YidC-GFP, no large decrease or
unstable AraH-GFP production was observed for stronger
BCD elements, and the strongest BCD2 produced at similar
high levels as BCD19 (Figure 2e). AraH-GFP production by
BCD19 and BCD2 was compared to the production by a
previously optimized pET vector (pET-opt-AraH-GFP), which
was obtained by screening a large library of vectors with
mutations around the start codon.14 The volumetric
production by both BCDs was found to be higher than that
of pET-opt-AraH-GFP under the originally optimized
Figure 1. Expression vector design and assembly. (a) The standard
expression vector contains a medium-strength constitutive promoter,
RBS1, which allows for strong translation initiation of a leader
peptide, and a translationally coupled, variable RBS2, mediating
translation initiation of the coding sequence (CDS) of the membrane
protein of interest.18 (b) Vectors are assembled with diﬀerent BCD
elements. First, the vector is ampliﬁed by PCR, subsequently it is
digested by type IIS restriction enzymes. The latter allows for
seamless assembly with a library of annealed oligo pairs (encoding the
diﬀerent BCD variants), which have overhangs complementary to the
digested vector.
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Figure 2. Production of YidC-GFP, AraH-GFP, and rhodopsins by BCD elements and comparison to state-of-the art systems. (a) Volumetric
YidC-GFP production based on whole-cell ﬂuorescence measurements and ﬁnal growth yields for the BCD constructs, and a comparison to
Lemo21(DE3)-based production at optimized (2 mM L-rhamnose) and nonoptimized (0 mM L-rhamnose) conditions. BCD variants are ordered
in the X-axis based on previously reported translation initiation strength.18 (b) Western blots performed with antihis-tag antibody (upper panels) to
visualize both inclusion body and well-folded YidC-GFP-his, and anti-IbpB6,21 (lower panels) to visualize inclusion body binding protein B. (c)
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conditions, mainly due to a higher biomass yield (Figure 2e,
Figure S2). Production by the BCDs also resulted in less
inclusion body binding protein than pET-based production,
while a nonfolded protein could not be clearly detected in
Western blot for any construct (Figure 2f). Additionally,
production by pET-opt-AraH-GFP resulted in a small
emerging nonproducing population of cells after 22 h of
cultivation, as revealed by ﬂow cytometry analysis, while
production by the BCD elements was still fully homogeneous
(Figure 2g). Notably, by screening a library of only 22 BCD
variants, we were able to ﬁnd clones for which the production
was comparable (per cell) or even better (per volume) than
that of the previously optimized pET-opt-AraH-GFP, which
required the high-throughput screening of a large library of
variants (1.6 × 104) through ﬂuorescence-activated cell
sorting (FACS).14
To further estimate the production stability of the medium-
strength, high-producing BCD19 and the strongest translation
initiation element BCD2, we assessed production per cell by
ﬂow cytometry during longer serial cultivation experiments up
to 72 h. Remarkably, BCD19-YidC-GFP, and for AraH both
BCD19 and BCD2, result in stable homogeneously producing
populations, even after 72 h (Figure 2d,h, Figure S3). For
BCD2-YidC-GFP, however, only 2 out of 4 precultures
prepared for the stability experiment maintained their initial
production level, despite the fact that the colonies used for
initial inoculation were selected on the basis of high
ﬂuorescence. This demonstrated again an unstable production
phenotype for the strong BCD2 with YidC, as observed we
observed in earlier experiments. The two stably producing
precultures were further inoculated for the long-term experi-
ment in fresh medium, and their production decreased over the
course of time (Figure 2d, Figure S3). The strong translation
initiation of YidC-GFP driven by BCD2 seemed to stress the
cells, favoring the emergence of nonexpressing cells in the
population (Figure 2d), which may have been caused by
suppressing mutations in plasmids or the genome (not further
characterized).
The BCD system was further employed to optimize the
production of bacterial rhodopsin proteins. These simple
membrane-bound light-harvesting energy systems can be
employed for light-driven cell-factories25 or optogenetic
regulation.26 When properly folded in the cytoplasmic
membrane, rhodopsins are known to bind the retinal pigment,
leading to red pigmentation of the host cells.27,28 Rather than
cloning all the BCDs in parallel, this time the 22 BCD variants
were pooled, cloned into the vectors containing GR or TR, and
transformed as a library. Clones of the resulting transformation
were then randomly picked and grown in 96-well plates with
retinal (Figure S4). For both GR and TR, 11 clearly red-
pigmented pellets were identiﬁed out of 89 and 96 screened
clones, respectively. For each of the rhodopsin proteins, three
intensely red clones were selected for further characterization.
In the case of GR, one of the selected clones contained BCD14
and the other two carried BCD15. For TR, BCD9, BCD12,
and BCD21 were identiﬁed. All these variants are in the
medium-strength range of the BCD system.
Production of GR and TR by the best rhodopsin-producing
BCD variants was scaled up from deep-well plates to 10 mL
cultures in 50 mL tubes. While all elements rendered very
similar levels of GR expression (Figure 2i), the production of
TR signiﬁcantly diﬀered from one BCD to another; BCD9
performed signiﬁcantly better than BCD12, while BCD21 gave
the lowest production (Figure 2j). These three variants
performed very similar when grown in deep-96-well plates,
while the results of the production assays in 50 mL tubes are
signiﬁcantly diﬀerent. This indicates that results are not always
comparable when scaling-up from deep-well plates (0.5 mL
culture) to test tubes (10 mL culture). The previously
discussed strains of YidC-GFP and AraH-GFP were
initially grown directly in 10 mL cultures in 50 mL tubes,
and now compared with their performance in deep-well plates
(0.5 mL culture) (Figure S5), conﬁrming diﬀerences in
performance depending on culture conditions. This reﬂects
the common challenge of optimizing and scaling up
recombinant production. However, the optimization for the
BCD system in scaled-up conditions is quite feasible given the
limited number of tuning variants that need to be tested.
We then compared the production of GR and TR to the
levels produced by the Lemo21(DE3) system, which was
optimized in tubes. Compared to rhodopsin production by the
Lemo21(DE3) system, the best performing BCD variants for
GR and TR resulted in at least 2-fold and 3-fold higher
volumetric rhodopsin production, respectively (Figure 2i,j).
The here employed BCD system outperforms the membrane
protein productivities of previously established approaches.
Moreover, the BCD system provides stable membrane protein
production for at least 72 h, a stability never reported to date.
While most current systems for membrane protein production
are limited to speciﬁc E. coli strains, the applied P14
constitutive promoter allows our system to be generally
applicable in all E. coli strains. By applying the principles of our
method and potentially including diﬀerent promoters and/or
BCDs, our system is likely feasible for bacterial membrane
protein production in other bacterial hosts as well. The BCD
system may also be applicable for producing certain eukaryotic
Figure 2. continued
Single-cell production of YidC-GFP analyzed by ﬂow cytometry for several increasing strength BCD elements and optimized Lemo21(DE3). (d)
Single-cell production of YidC-GFP by BCD19 and BCD2 in a 72 h stability experiment. (e) Volumetric AraH-GFP production based on whole-
cell ﬂuorescence measurements and ﬁnal growth yields for the BCD constructs, and a comparison to pET-opt-AraH-GFP.14 BCD variants are
ordered in the X-axis based on previously reported variant strength.18 (f) Western blots performed with antihis-tag antibody (upper panels) to
visualize both AraH-GFP-his, and anti-IbpB6,21 (lower panels) to visualize inclusion body binding protein. (g) Single-cell production of AraH-GFP
analyzed by ﬂow cytometry for several increasing strength BCD elements and pET-opt-AraH-GFP. (h) Single-cell production of AraH-GFP by
BCD19 and BCD2 in a 72 h stability experiment. (i) Volumetric Gloeobacter Rhodopsin (GR) and (j) Thermophilic Rhodopsin (TR) production
determined by spectroscopy, and pictures of red-pigmented pellets. All cultivations were performed in 10 mL of medium in 50 mL tubes, for YidC-
AraH and AraH-GFP at 30 °C, for rhodopsins GR and TR at 37 °C, and for pET-opt-AraH-GFP in E. coli BL21(DE3) pLysS at 25 °C (as
optimized for in original work). BCD-based production was measured after 22 h of cultivation, while Lemo21(DE3) and pET based production
was measured after 22 h of induction. Whole-cell ﬂuorescence or rhodopsin quantiﬁcation data are based on at least three biological replicates. For
72 h stability experiments E. coli BL21(DE3) harboring BCD vectors were reinoculated 1:50 into fresh LB kanamycin medium every 24 h.
Notation: RFU, relative ﬂuorescence units; OD600, optimal density of 600 nm.
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membrane proteins in E. coli, although expression of eukaryotic
proteins in bacterial hosts may lead to issues that cannot be
solved just by tuning expression strength and tackling RBS-
accessibility, this includes issues as glycosylation or the
requirement of eukaryotic-like membrane lipids.1 Overall, it is
anticipated that the here described approach for bacterial
membrane protein production will be useful for many future
studies, ranging from biochemical characterization to cell
factory and biosensor engineering.
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